InvestorsHub Logo

elks

10/05/18 9:31 PM

#90960 RE: VortMax #90944

The Company is also engaging the FDA for clearance to market RadioGel™ for the treatment of advanced basal and squamous cell skin cancers in humans.

wrinklesobw

10/05/18 10:40 PM

#90988 RE: VortMax #90944

First you are right will be a big cost to a local vet, IsoPet is not going after them, they are going after established vet hospitals that can handle that kind of treatment.

RAND

10/07/18 11:30 PM

#92062 RE: VortMax #90944

just watch vortmax

RAND

10/08/18 1:30 AM

#92100 RE: VortMax #90944

An important difference of RadioGel to older #brachytherapy products is, the minimally invasive radiation that is emitted to adjacent healthy tissue. RGL has achieved a very high therapeutic index in animal testing